Geode Capital Management, LLC Catalyst Biosciences, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.33 - $0.65 $3,724 - $7,336	-11,287 Reduced 4.18%	258,746 $124,000
Q1 2023 May 15, 2023	SELL	$0.19 - $0.64 $865 - $2,914	-4,554 Reduced 1.66%	270,033 $56,000
Q4 2022 Feb 13, 2023	SELL	$0.49 - $0.57 $332 - $386	-678 Reduced 0.25%	274,587 $144,000
Q2 2022 Aug 12, 2022	SELL	$0.36 - $1.78 $8,616 - $42,606	-23,936 Reduced 8.0%	275,265 $489,000
Q1 2022 May 13, 2022	BUY	$0.51 - $1.0 $6,434 - $12,616	12,616 Added 4.4%	299,201 $197,000
Q4 2021 Feb 11, 2022	SELL	$0.91 - $4.16 $59,109 - $270,216	-64,956 Reduced 18.48%	286,585 $261,000
Q3 2021 Nov 12, 2021	BUY	$3.78 - $5.18 $72,054 - $98,741	19,062 Added 5.73%	351,541 $1.44 Million
Q2 2021 Aug 13, 2021	SELL	$4.1 - $5.33 $827,761 - $1.08 Million	-201,893 Reduced 37.78%	332,479 $1.44 Million
Q1 2021 May 12, 2021	BUY	$4.93 - $7.15 $1.07 Million - $1.55 Million	217,046 Added 68.4%	534,372 $2.69 Million
Q4 2020 Feb 12, 2021	BUY	$4.55 - $7.29 $142,455 - $228,242	31,309 Added 10.95%	317,326 $2 Million
Q3 2020 Nov 13, 2020	BUY	$4.22 - $6.04 $184,042 - $263,416	43,612 Added 17.99%	286,017 $1.23 Million
Q2 2020 Aug 13, 2020	BUY	$3.76 - $8.01 $465,251 - $991,133	123,737 Added 104.27%	242,405 $1.42 Million
Q1 2020 May 14, 2020	BUY	$3.5 - $8.51 $42,266 - $102,766	12,076 Added 11.33%	118,668 $518,000
Q3 2019 Nov 12, 2019	BUY	$4.91 - $9.31 $67,267 - $127,547	13,700 Added 14.75%	106,592 $523,000
Q2 2019 Aug 14, 2019	SELL	$7.08 - $10.6 $318,472 - $476,809	-44,982 Reduced 32.63%	92,892 $684,000
Q1 2019 May 14, 2019	SELL	$7.67 - $9.96 $48,328 - $62,757	-6,301 Reduced 4.37%	137,874 $1.12 Million
Q4 2018 Feb 13, 2019	BUY	$6.59 - $11.28 $35,618 - $60,968	5,405 Added 3.89%	144,175 $1.14 Million
Q3 2018 Nov 13, 2018	SELL	$9.35 - $12.44 $263,314 - $350,335	-28,162 Reduced 16.87%	138,770 $1.5 Million
Q2 2018 Aug 14, 2018	BUY	$9.11 - $28.88 $948,870 - $3.01 Million	104,157 Added 165.92%	166,932 $1.95 Million
Q1 2018 May 15, 2018	BUY	$14.18 - $35.6 $495,902 - $1.25 Million	34,972 Added 125.78%	62,775 $1.62 Million
Q4 2017 Feb 13, 2018	BUY	$4.52 - $13.69 $125,669 - $380,623	27,803 New	27,803 $379,000
Q3 2017 Nov 14, 2017	SELL	$3.19 - $5.1 $39,658 - $63,403	-12,432 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	12,432	12,432 $57,000

Others Institutions Holding CBIO

# of Institutions

Shares Held

215

Call Options Held

Put Options Held

American Portfolios Advisors Holbrook, NY

215
Shares

$0
0.0% of portfolio

View Full List

About CATALYST BIOSCIENCES, INC.

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

More about CBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account